Episode Details
Back to EpisodesBig Week Ahead For Stocks… And Emergent’s Mpox Approval 8/30/24
Published 1 year, 6 months ago
Description
August trading is in the books, and after a rough start to the month, stocks managed to rebound. But with a big week on deck, can the bounce back continue? Plus Biotech company Emergent Bio getting FDA approval for its smallpox vaccine to treat mpox. What it could mean for Emergent’s future and the space as a whole.